{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:31:08Z","timestamp":1791549068350,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.rbmo.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T13:17:36Z","timestamp":1525699056000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters"],"prefix":"10.1016","volume":"37","author":[{"given":"Michel","family":"De Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Pareyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Drakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9471-2639","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Raimundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Anckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Santos-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos P.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2018.05.003_bib0010","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.fertnstert.2011.02.057","article-title":"Age-related normograms of serum antim\u00fcllerian hormone levels in a population of infertile women: a multicentre study","volume":"95","author":"Almog","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clinbiochem.2015.10.008","article-title":"Multicentre analytical performance evaluation of a fully automated anti-M\u00fcllerian hormone assay and reference interval determination","volume":"49","author":"Anckaert","year":"2016","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antim\u00fcllerian hormone in gonadotrophin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0025","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone\u2013stratified, dose\u2013response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajog.2011.04.035","article-title":"Use of in-cycle antimullerian hormone levels to predict cycle outcome","volume":"205","author":"Blazar","year":"2011","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/humrep\/deu272","article-title":"Can you ever collect too many oocytes?","volume":"30","author":"Briggs","year":"2015","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0055","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antim\u00fcllerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"Brodin","year":"2013","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0060","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/humrep\/dew219","article-title":"Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle","volume":"31","author":"De Vos","year":"2016","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0065","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0070","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Defi- nition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0080","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0085","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-M\u00fcllerian hormone and oestradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0090","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.fertnstert.2007.05.040","article-title":"Anti-M\u00fcllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients","volume":"89","author":"Elgindy","year":"2008","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0095","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/humrep\/des389","article-title":"High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol","volume":"28","author":"Fatemi","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0100","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.fertnstert.2010.04.067","article-title":"Anti-M\u00fcllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve","volume":"94","author":"Gleicher","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0105","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1210\/jc.2011-2366","article-title":"Loss of WT1 expression in the endometrium of infertile PCOS patients: a hyperandrogenic effect?","volume":"97","author":"Gonzalez","year":"2012","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149615","article-title":"Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH Antagonist Protocol","volume":"11","author":"Griesinger","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.fertnstert.2015.06.030","article-title":"Antim\u00fcllerian hormone: prediction of cumulative live birth in gonadotrophin-releasing hormone antagonist treatment for in vitro fertilization","volume":"104","author":"Hamdine","year":"2015","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","article-title":"Preventing ovarian hyperstimulation syndrome: guidance for the clinician","volume":"94","author":"Humaidan","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0125","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0130","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/humrep\/det303","article-title":"The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China","volume":"28","author":"Ji","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0135","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dev187","article-title":"Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions","volume":"30","author":"Kollmann","year":"2015","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2010.08.011","article-title":"Development of a second generation antim\u00fcllerian hormone (AMH) ELISA","volume":"362","author":"Kumar","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","article-title":"Anti-M\u00fcllerian hormone-based prediction model for a live birth in assisted reproduction","volume":"22","author":"La Marca","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0150","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/molehr\/gat065","article-title":"Involvement of androgens in ovarian health and disease","volume":"19","author":"Lebbe","year":"2013","journal-title":"Mol. Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-M\u00fcllerian hormone and oestradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee","year":"2008","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1423-0127-21-2","article-title":"Endometrial progesterone resistance and PCOS","volume":"21","author":"Li","year":"2014","journal-title":"J. Biomed. Sci"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0165","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2013implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicentre, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0175","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/ijo.2016.154","article-title":"Proinflammatory environment and role of TNF-\u03b1 in endometrial function of obese women having polycystic ovarian syndrome","volume":"40","author":"Orostica","year":"2016","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0180","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0185","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.rbmo.2016.01.010","article-title":"Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-M\u00fcllerian hormone","volume":"32","author":"Ramezanali","year":"2016","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0200","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/humrep\/deu335","article-title":"Direct actions of androgens on the survival, growth and secretion of steroids and anti-M\u00fcllerian hormone by individual macaque follicles during three-dimensional culture","volume":"30","author":"Rodrigues","year":"2015","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0205","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/1933719115618283","article-title":"Hyperandrogenism Decreases GRP78 Protein Level and Glucose Uptake in Human Endometrial Stromal Cells","volume":"23","author":"Rosas","year":"2016","journal-title":"Reprod. Sci"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0210","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/09513590.2013.769519","article-title":"Anti-M\u00fcllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients","volume":"29","author":"Sahmay","year":"2013","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0215","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0220","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2018.05.003_bib0230","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","article-title":"Correlation of serum Anti-M\u00fcllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients","volume":"29","author":"Xi","year":"2012","journal-title":"J. Assist. Reprod. Genet"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264831830258X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264831830258X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T19:54:26Z","timestamp":1533066866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147264831830258X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S147264831830258X"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2018.05.003","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}